Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff is a Product of the Generic Budesonide

What Is Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff Indications and Uses?

Aeronid inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and paediatric patients six years of age or older. It is also indicated for patients requiring oral corticosteroid therapy for asthma, many of those patients may be able to reduce or eliminate their requirement for oral corticosteroids over time. Aeronid inhaler is not indicated for the relief of acute bronchospasm.

Pharmacology (Source, Chemical and Physical Composition) Of Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff

Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff (Budesonide) inhaler is a corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Corticosteroids have been shown to have a wide range of inhibitory activities against multiple cell types (e.g., mast cells, oeosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in allergic and non-allergic inflammation. These anti-inflammatory actions of Budesonide contribute to its efficacy in asthma.

Side Effects of Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff

The following adverse reactions were reported in patients treated with Aeronid inhaler. General: Headache, flu-like syndrome, pain, back pain, fever, neck pain, asthenia. Respiratory system: Respiratory tract infections, pharyngitis, sinusitis, rhinitis, voice alteration, cough aggravation. Digestive system: Oral candidiasis, dyspepsia, gastroenteritis, nausea, abdominal pain, dry mouth, vomiting. Metabolic and Nutritional: Weight gain. Musculoskeletal: Fracture, myalgia, arthralgia. Nervous system: Syncope, hypertonia, migraine. Skin: Ecchymosis. Psychiatric: Insomnia. Resistance Mechanisms: Infection. Special Senses: Taste perversion.

Precautions And Warnings for Aeronid Metered-Dose Inhaler (MDI) Inhaler 200 mcg/puff

During withdrawal from oral corticosteroids, some patients may experience symptoms of systemically active corticosteroid withdrawal, e.g., joint and/or muscular pain, lassitude, and depression, despite maintenance or even improvement of respiratory function. Aeronid inhaler will often permit control of asthma symptoms with less suppression of hypothalamic-pituitary-adrenal (HPA) function than therapeutically equivalent oral doses of Prednisone. Since Aeronid is absorbed into the circulation and can be systemically active at higher doses, the full beneficial effects of Aeronid inhaler in minimising HPA dysfunction may be expected only when recommended dosages are not exceeded and individual patients are titrated to the lowest effective dose. Since individual sensitivity to effects on cortisol production exists, physicians should consider this fact when prescribing Aeronid inhaler.

Therapeutic Class

Nasal Decongestants & Other Nasal Preparations, Respiratory corticosteroids

Storage Conditions of It

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children. Pack Images: Aeronid 200 mcg Inhaler Thanks for using MedEx! How would you rate your experience so far?